Tag Archive for: health canada
The Biggest Psychedelic News Stories of the Week – April 14
Policy, ResearchA wave of psychedelic news has hit the headlines as we see multiple states pushing for the decriminalization and advancement of psychedelics.
The Biggest Psychedelic News Stories This Week – March 10
Business, PolicyHealth Canada's decision to deny a terminally ill Saskatoon man permission to continue psychedelic psilocybin therapy has drawn a lot of attention and criticism from psychedelic advocates.
Are Magic Mushrooms Legal in Canada? How Do I Legally Get Access?
Beginners, ResearchNo, magic mushrooms are illegal in Canada. Psilocybin is strictly prohibited under Schedule III of the CDSA.
Health Canada’s Dealer’s Licence & Section 56 Explained with Benjamin Lightburn
PodcastsBenjamin Lightburn of Filament Health discusses the ins and outs of being a licensed dealer of naturally derived psilocybin in Canada and internationally.
Yep – Legal Ayahuasca Churches Are a Thing in Montreal
Culture, Human healthThe ayahuasca church was granted an exemption on religious grounds and is one of six Canadian organizations allowed to utilize it.
Psychedelic Business Spotlight – June 17
Business, News, Stock ReportsThis week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!
Psychedelic Business Spotlight – May 20
Business, Stock ReportsThis week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.
MAPS Navigates Multiple Scandals: Why Health Canada Is Reviewing MDMA Trials
ResearchA sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader MAPS, currently being scrutinized by Health Canada.
Psychedelic Business Spotlight- March 11
Business, Stock ReportsThis week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves a psilocybin PTSD study.
How Psychedelic Treatment Through Canada’s SAP Works
PolicyTwo psychedelic industry insiders reflect on the progress and flaws within Health Canada's recent amendment to the Special Access Program.